Mucocutaneous reactions to chemotherapy (Q33539859)

27 July 2017

1 reference

title

Mucocutaneous reactions to chemotherapy. (English)

1 reference

27 July 2017

1 reference

W S Susser

1

1 reference

27 July 2017

D L Whitaker-Worth

series ordinal

2

1 reference

27 July 2017

J M Grant-Kels

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

Journal of the American Academy of Dermatology

27 July 2017

published in

1 reference

27 July 2017

volume

40

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

367-98; quiz 399-400

1 reference

27 July 2017

cites work

Drug-associated alopecia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis associated with induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Minoxidil (Mx) as a prophylaxis of doxorubicin--induced alopecia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

A randomized trial of minoxidil in chemotherapy-induced alopecia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acute mucocutaneous toxicity following high-dose hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Dose–Finding Study of 5’-Deoxy-5-Fluorouridine in Combination with Fixed Doses of Cisplatin and L -Folinic Acid for the Treatment of Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Drug-induced mouth disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cancer therapy and oral mucositis. An appraisal of drug prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cutaneous complications of chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Antidotes to vesicant chemotherapy extravasations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Prevention and Management of Extravasation of Cytotoxic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Ifosfamide extravasation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Etiology and treatment of chemotherapeutic agent extravasation injuries: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cancer chemotherapy agent-induced perivenous extravasation injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Taxol-induced soft-tissue injury secondary to extravasation: characterization by histopathology and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Taxol extravasation: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Combined management in the treatment of epidoxorubicin extravasation. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Delayed treatment of vindesine extravasation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Conservative approach to the treatment of chemotherapy-induced extravasation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Paclitaxel-induced "recall" soft tissue injury occurring at the site of previous extravasation with subsequent intravenous treatment in a different limb

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Erythematous eruption of the palms and soles associated with mitotane therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chemotherapy-induced acral erythema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Fluorouracil and palmar-plantar erythrodysesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Taxol-induced acral erythema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chemotherapy-induced acral erythema: desquamating lesions involving the hands and feet

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acral erythema and hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Bullous variant of chemotherapy-induced acral erythema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acute Cutaneous Reactions to Docetaxel, a New Chemotherapeutic Agent

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Combination chemotherapy with tauromustine (TCNU), 5-fluorouracil and leucovorin in advanced colorectal carcinoma: a dose-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Diagnosis in oncology. Hand-foot syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acral erythema and systemic toxicity related to CHA induction therapy in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Phase I-II trial of doxifluridine (5'DFUR) administered as long-term continuous infusion using a portable infusion pump for advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chemotherapy-induced painful acral erythema in childhood: Burgdorf's reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Pyridoxine for the palmar-plantar erythrodysesthesia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Treatment of cytarabine acral erythema with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation recall supraglottitis. A hazard in head and neck chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Ultraviolet recall associated with etoposide and cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation recall and radiosensitization with alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Paclitaxel-induced radiation recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Taxol and radiation recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Paclitaxel and radiation-recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation-recall dermatitis in a patient treated with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Paclitaxel-induced radiation recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Potentiation of x-ray effects by actinomycin D

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation recall induced by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation recall in a patient with breast cancer treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation recall reaction to idarubicin resulting in vaginal necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation Recall Dermatitis Induced by Edatrexate in a Patient with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Toxicity of combined radiation and chemotherapy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Radiotherapy in the management of cutaneous epidemic Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Photosensitivity Due to a Fluorouracil Derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Methotrexate Reactivation of Sunburn Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Mucocutaneous side effects of Brequinar sodium. A new inhibitor of pyrimidine de novo biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Phase I/pharmacokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cutaneous photosensitivity diseases induced by exogenous agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Photosensitive dermatitis induced by flutamide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Flutamide photosensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cutaneous phototoxic occurrences in patients receiving Photofrin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Skin changes in patients treated with 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Inflammation of actinic keratoses induced by cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Inflammation of actinic keratoses from systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

An oncology patient with an erythematous papulosquamous eruption in sun-exposed areas. Inflamed actinic keratoses due to systemic chemotherapy (fluorouracil and, possibly, interferon alfa)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Inflammation of solar keratoses following systemic 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cytarabine-Induced Inflammation in the Seborrheic Keratoses of Leser-Trélat

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity reactions from antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

The red face: flushing disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Flushing reactions in the cancer chemotherapy patient. The lists are longer but the strategies are the same

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

The acute toxicities of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Carboplatin hypersensitivity in children. A report of five patients with brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Facial flushing--a side effect of pulse therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Successful docetaxel rechallenge with cromoglycate after major sensitivity reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Doxorubicin-associated facial flushing

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity reactions to etoposide. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

The red face: drugs, chemicals and other causes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Management of cutaneous symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Metabolic and toxic effects of mithramycin during tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Drugs 5 years later: procarbazine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis: A distinctive rash associated with cytarabine therapy and acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis associated with Hodgkin's disease and chemotherapy. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis. Evidence implicating bleomycin as a causative agent

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chemotherapy-associated eccrine hidradenitis: neutrophilic eccrine hidradenitis reevaluated: the role of neutrophilic infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis--a report of two additional cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Asymptomatic erythematous papules in a leukemic patient. Neutrophilic eccrine hidradenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Intradermal bleomycin injections into normal human skin. A histopathologic and immunopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Recurrent neutrophilic eccrine hidradenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Annular plaques on the dorsa of the hands. Neutrophilic eccrine hidradenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis simulating orbital cellulitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis in HIV-infected patients. Armed Forces Retrovirus Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Infectious eccrine hidradenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis heralding the onset of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis with an unusual presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic dermatoses during granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic hidradenitis induced by chemotherapy involves eccrine and apocrine glands

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Observations and proposed mechanism of N,N',N''-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Excretion of mutagens in sweat from humans treated with anti-neoplastic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Neutrophilic eccrine hidradenitis. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Herpetic syringitis associated with eccrine squamous syringometaplasia in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Eccrine squamous syringometaplasia in intertriginous areas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Necrotizing eccrine squamous syringometaplasia presenting as acral erythema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Recall phenomenon with the unusual presence of eccrine squamous syringometaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

A papulovesicular eruption in a man receiving chemotherapy for metastatic melanoma. Squamous syringometaplasia (squamous metaplasia) of the eccrine glands

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cutaneous eruptions of lymphocyte recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Systemic cytokine administration alters the histology of the eruption of lymphocyte recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acute cutaneous eruptions after marrow ablation: roses by other names?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

New histopathologic findings in drug eruptions.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Changes in melanosome distribution in Caucasoid skin following topical application of nitrogen mustard.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Effects of Topical Mechlorethamine on Skin Lesions of Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Drug-induced hair colour changes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Ifosfamide-induced hyperpigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Ifosfamide-induced hyperpigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Pigmentation due to a new antitumor agent. Effects of topical application of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea]

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Serpentine supravenous hyperpigmentation induced by the nitrosourea fotemustine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Localized cisplatin hyperpigmentation induced by pressure. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Unusual serpentine hyperpigmentation associated with 5-fluorouracil. Case report and review of cutaneous manifestations associated with systemic 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Reticulate pigmentation due to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Weekly psoriasis therapy using intralesional fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

The flag sign of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

'Flagellate' erythema in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Flagellate pigmentation from intrapleural bleomycin. A light microscopy and electron microscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hyperpigmentation in striae distensae after bleomycin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cutaneous hyperpigmentation caused by systemic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hyperpigmentation with daunorubicin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cutaneous pigmentation after daunorubicin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Blue‐gray Pigmentation in a Patient Receiving Doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Supravenous hyperpigmentation induced by vinorelbine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Discrete Pigmentation After Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Red hair and hyperpigmentation in a black man after chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chemotherapy-associated supravenous hyperpigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cyclophosphamide induced nail pigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Nail changes secondary to systemic drugs or ingestants

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Transverse leukonychia (Mees' lines) due to daunorubicin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hydroxyurea-induced nail pigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Transverse white lines in the fingernails induced by combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Leukonychia due to cytostatic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Pigmentary effects from the protracted infusion of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cyclophosphamide and pigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Anaphylactoid reactions to methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Coping with toxicities of docetaxel (Taxotere)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Adverse reactions to the intravesical administration of doxorubicin hydrochloride: report of 6 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Generalized hypersensitivity reaction to intravesical thiotepa and doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity reactions from taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Carboplatin hypersensitivity: case reports and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Allergic reactions to mitoxantrone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

The prevention and treatment of immediate hypersensitivity reactions from cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Allergic reactions to cytotoxic drugs--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Morbilliform Skin Eruption Owing to Diethylstilbestrol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acute allergic reaction due to vincristine sulfate. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Stevens-Johnson syndrome associated with topical nitrogen mustard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Erythema multiforme induced by suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Methotrexate-induced erythema multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Stevens-Johnson syndrome, respiratory distress and acute renal failure due to synergic bleomycin-cisplatin toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Stevens-Johnson syndrome and fatal pulmonary toxicity to combination chemotherapy containing bleomycin: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Stevens-Johnson syndrome during an immunosuppressive therapy with cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Stevens-Johnson syndrome induced by cyclophosphamide: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chlorambucil allergy--a series of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Methotrexate-induced necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Unusual reaction to chlorambucil: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Toxic epidermal necrolysis during chlorambucil therapy in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Severe adverse skin reaction to chlorambucil in a patient with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Fatal toxic epidermal necrolysis during suramin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Cutaneous vasculitis due to cyclophosphamide therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Tamoxifen and purpuric vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Occupational contact urticaria due to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Systemic contact dermatitis from 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Treatment of keratoacanthoma with topical application of fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Allergic contact dermatitis to 5-fluorouracil.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Pustular contact hypersensitivity to fluorouracil with rosacealike sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Topical chemotherapy with 5-fluorouracil. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Generalized dermatitis due to mitomycin C patch test

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Three cases of allergic dermatitis due to intravesical mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Allergic contact dermatitis from mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Delayed-type sensitivity reaction to mitomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Dermatitis due to mitomycin C bladder instillations: study of 2 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity reactions to etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Skin Reactions to 5-Fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Bone marrow aplasia and severe skin rash after a single low dose of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Skin rash following therapy with mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity reaction to high-dose cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity reactions to CHIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Allergic reaction to intravesical adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Raynaud's Phenomenon Progressing to Gangrene after Vincristine and Bleomycin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Digital gangrene following chemotherapy for AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Chemotherapy-induced Raynaud's phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

A case of bleomycin-induced scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Severe exfoliative dermatitis associated with hand ischemia during cisplatin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Unusual Local Cutaneous Reaction to Dacarbazine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Procarbazine hypersensitivity manifested as a fixed drug eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hydroxyurea-induced dermatomyositis-like eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Pseudo-dermatomyositis induced by long-term hydroxyurea therapy: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Suramin keratosis: a unique skin eruption in a patient receiving suramin for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Intermittent high dose oral methotrexate therapy in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Severe acne and hyperandrogenemia following dactinomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Systemic lupus erythematosus induced by aminoglutethimide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Hydroxyurea-induced lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Immunological changes in hydroxyurea-induced collagen disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Mucocutaneous side effects of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Bullous pemphigoid after chemotherapy for choriocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Tamoxifen-induced hair colour change

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acanthosis nigricans following diethylstilbestrol therapy. Occurrence in patients with childhood muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Severe mucocutaneous reaction to aminoglutethamide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

Acquired cutaneous adherence in patients with androgen-independent prostate cancer receiving ketoconazole and doxorubicin: medication-induced sticky skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970488-3

7 January 2021

10.1016/S0190-9622(99)70488-3

Identifiers

DOI

1 reference

27 July 2017

1 reference